Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Contribution of CD133 Gene Polymorphisms to Cancer Risk: Integrating Case-Control Evidence With Meta-Analysis.

Genes, chromosomes & cancer - 1 Aug 2026

Zhang Xinyi, Zhou Hang, Li Yongwei, Chu Yuping, Li Boyu, Dai Jiaxuan, Yang Qinyue, Feng Xianhong, Chen Bifeng

Abstract excerpt

Previous studies have extensively examined the associations between CD133 gene polymorphisms (rs10022537, rs2286455, rs2240688, and rs3130) and cancer risk, but have yielded inconsistent results. This study aimed to investigate the potential contributions of these polymorphisms to the susceptibility of liver, lung, and gastric cancers through a replicated case-control study and a subsequent systematic...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AC133 Antigen
Share to Aged
Share to Case-Control Studies
Share to Genetic Predisposition to Disease
Share to Liver Neoplasms
Share to Lung Neoplasms
Share to Polymorphism, Single Nucleotide
Share to Stomach Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 42583819
DOI: 10.1002/gcc.70162
PMCID: PMC13463280

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Contribution of CD133 Gene Polymorphisms to Cancer Risk: Integrating Case-Control Evidence With Meta-Analysis.PMID 42583819Read ↗

Effect of CD133 polymorphisms on the risk of developing liver cirrhosis and hepatocellular carcinoma induced by viral hepatitis.Semantic proximity Read ↗

Polymorphisms of the Stem Cell Marker Gene CD133 and the Risk of Lung Cancer in Chinese Population.Semantic proximity Read ↗

Polymorphisms of the stem cell marker gene CD133 are associated the clinical outcome in a cohort of Chinese non-small cell lung cancer patients.Semantic proximity Read ↗

Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer.Semantic proximity Read ↗

An investigation of the effects of B7-H4 gene rs10754339 and miR‐125a gene rs12976445 on cancer susceptibilitySemantic proximity Read ↗

A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 expression.Semantic proximity Read ↗

Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case-control studies.Semantic proximity Read ↗

Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer.Semantic proximity Read ↗

A risk prediction model for colorectal cancer using genome-wide association study-identified polymorphisms and established risk factors among Japanese: results from two independent case-control studies.Semantic proximity Read ↗

Quantitative assessment of CD44 genetic variants and cancer susceptibility in Asians: a meta-analysis.Semantic proximity Read ↗

CTLA-4 polymorphisms and predisposition to digestive system malignancies: a meta-analysis of 31 published studies.Semantic proximity Read ↗

Single nucleotide polymorphisms associated with colorectal cancer susceptibility and loss of heterozygosity in a Taiwanese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.